Instructions for use Kolikid film-coated tablets 125 mg No. 30
Composition
active ingredient: simethicone;
1 tablet contains simethicone 125 mg;
excipients: magnesium aluminum silicate, lactose monohydrate, microcrystalline cellulose, calcium hydrogen phosphate, stearic acid, colloidal anhydrous silicon dioxide, crospovidone, povidone K 29/32, Opadry II 85G 52218 yellow.
Dosage form
Film-coated tablets.
Main physicochemical properties: oval, smooth on both sides tablets, coated with a yellow shell.
Pharmacotherapeutic group
Drugs used in functional gastrointestinal disorders. Silicones.
ATX code A03A X13.
Pharmacological properties
Pharmacodynamics
Simethicone, which is part of the drug, is a non-toxic inert surfactant made on the basis of silicon, is an antifoam. It changes the surface tension of gas bubbles formed in the intestine and causes their destruction. The gases released in this case can either be absorbed by the intestinal walls or excreted from the body due to intestinal peristalsis. The use of simethicone before the start of diagnostic studies of the abdominal cavity prevents the appearance of image defects caused by gas bubbles; promotes thorough irrigation of the colon mucosa with a contrast agent, which prevents rupture of the contrast film even in the case of intestinal distension.
Pharmacokinetics
Simethicone acts exclusively on the surface of gas bubbles and is not absorbed by the mucous membrane of the digestive tract. Simethicone is not absorbed by the mucous membrane of the digestive tract and is excreted unchanged after oral administration. Simethicone has no central action.
Indication
Symptomatic treatment of gastrointestinal disorders associated with gas formation, such as flatulence, including in the postoperative period. As an aid in diagnostic examinations of the abdominal organs (radiography, ultrasound) and in preparation for gastroduodenoscopy. As an antifoam in intoxications with surfactants (washing powders or other detergents).
Contraindication
Hypersensitivity to the drug and its components. Intestinal obstruction. Obstructive diseases of the digestive tract.
Interaction with other medicinal products and other types of interactions
The simultaneous use of simethicone and laxatives containing mineral oil (paraffin) is not recommended, since mixing these substances leads to a decrease in the effectiveness of simethicone.
Levothyroxine may bind to simethicone. The absorption of levothyroxine in the intestine may be impaired when taken simultaneously with simethicone.
Application features
If gastrointestinal symptoms (complaints) recur or persist for more than 14 days or worsen, you should seek medical advice.
This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Ability to influence reaction speed when driving vehicles or other mechanisms
Since simethicone is an inert substance that is not absorbed, the effect on driving or other mechanisms is practically excluded.
Use during pregnancy or breastfeeding
There are no clinical data on the use of Kolikid in pregnant women. Since the active ingredient is not absorbed by the mucous membrane of the digestive tract, no effect of the drug on the fetus or accumulation of the drug in breast milk should be expected.
The use of the drug Kolikid® during pregnancy or breastfeeding is possible only when the expected benefit to the mother outweighs the potential risk to the fetus or child.
Method of administration and doses
Kolikid tablets should be taken orally by adults and children over 12 years of age. Taking the drug does not depend on meals.
Symptomatic treatment for gastrointestinal complaints: 1 tablet 3 times a day.
As an aid in conducting diagnostic examinations of the abdominal organs: 1 tablet 3 times a day the day before the examination and another 1 tablet in the morning on the day of its conduct.
As an antifoam for intoxications with surfactants (washing powders or other detergents): dosage depends on the severity of intoxication. The minimum recommended dose is 3 tablets.
The duration of treatment is determined individually. If necessary, the drug can be taken for a long time.
Children
Colicide, tablets, for use in children over 12 years of age.
Children under 12 years of age should be prescribed the drug in liquid dosage forms.
Overdose
To date, there are no known cases of overdose. Since simethicone is chemically and physiologically inert, intoxication is practically excluded. In case of using doses higher than recommended, you should consult a doctor.
Adverse reactions
Immune system disorders: allergic reactions, hypersensitivity reactions such as itching, skin rashes, urticaria, facial swelling, tongue swelling and difficulty breathing.
Gastrointestinal: nausea, constipation.
Expiration date
3 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
15 tablets in a blister; 2 blisters in a cardboard box.
Vacation category
Without a prescription.
Producer
"KUSUM FARM" LLC.
Location of the manufacturer and its business address
40020, Ukraine, Sumy region, Sumy city, Skryabina st., 54
